Company Filing History:
Years Active: 1990-1991
Title: Jane M Bindl: Innovator in Monoclonal Antibody Development
Introduction
Jane M Bindl is a prominent inventor based in Los Altos, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work has the potential to impact various medical applications.
Latest Patents
One of her latest patents is for L60, a novel monoclonal antibody that reacts with Leu 22. This innovative antibody demonstrates equal reactivity in formalin, ZnSO.sub.4, or Bouin's fixed, paraffin-embedded tissues, as well as in frozen tissues. The development of L60 showcases her expertise and dedication to advancing medical research.
Career Highlights
Jane M Bindl is currently associated with Becton Dickinson and Company Limited, where she continues to work on groundbreaking projects. Her role at the company allows her to collaborate with other experts in the field and contribute to the advancement of healthcare technologies.
Collaborations
One of her notable coworkers is David W Buck, with whom she has likely shared insights and expertise in their respective areas of research.
Conclusion
Jane M Bindl's contributions to the field of monoclonal antibodies exemplify her commitment to innovation in biotechnology. Her work continues to pave the way for advancements in medical research and applications.